Assistant Professor, General Surgery, Rush Medical College of Rush Univ
General Surgery
Dr. Stephen C. Jensik, MD
|
|
Give Review
Stephen C. Jensik works in the field of General Surgery. He graduated from University of Illinois College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Stephen C. Jensik, MD is a published doctor and has 44 publications published. The lastest was: 'Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.' Stephen Jensik is registered with Medicare and accepts Medicare payments.
Publications
- Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant.
- The characterization of Ia+ cells in human Parathyroid and islets.
- New developments in renal transplantation.
- Ultrarapid urokinase in hemodialysis access occlusion.
- Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.
- T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
- Amputations associated with arteriovenous access.
- Machine preservation of 450 cadaver kidneys.
- Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection.
- Efficient gene transfer and expression in islets by an adenoviral vector that lacks all viral genes.
- Percutaneous interventional radiologic procedures for diagnosis and treatment of urologic complications in renal transplant patients.
- Percutaneous transluminal angioplasty for transplant renal artery stenosis.
- Percutaneous treatment of urine leaks in renal transplantation patients.
- Rejection of renal allografts: prediction with a new Peripheral blood assay.
- Ultraviolet-B irradiation of leukapheresis. Products: dose-response relationship with the mixed lymphocyte reaction.
- Gene gun-mediated gene transfer and expression in rat islets.
- Comparison of viral gene-deleted adenoviral vectors with the E1-deleted adenoviral vector in islets.
- Microinvasive donor nephrectomy.
- Use of collagen injections for vesicoureteral reflux in transplanted kidneys.
- Sirolimus-based steroid-free maintenance immunosuppression.
- Renal transplant Arterial thrombosis: association with cyclosporine.
- Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
- Role of Fas in recurrence of autoimmune diabetes after islet transplantation.
- Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
- Leflunomide-based immunosuppression for porcine islet xenotransplantation.
- Renal transplantation without sutures using the Vascular clipping system for renal artery and vein anastomosis--a new technique.
- Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
- Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine.
- Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
- Leflunomide, a potential immunosuppressant for Pancreatic islet transplantation.
- Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
- Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
- Pharmacologically induced regression of chronic transplant rejection.
- In vivo effects of leflunomide on normal Pancreatic islet and syngeneic islet graft function.
- Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant St...
- Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide.
- YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.
- Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
- A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.
- An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with mod...
- Experiences with leflunomide in solid organ transplantation.
- Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
- A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.
Schools
Univ Of Il Coll Of Med
Fairview University Med Center
Rush Presby St Luke39s M C
Procedures Preformed
- Arteriovenous Shunt Creation
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Abdominal Pain
- Anorectal Abscess
- Atelectasis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Minnesota at Fairview -
Rush University Medical Center -
University of Illinois College of Medicine
Hospital
-
Rush University Medical Center -
Rush Oak Park Hospital
Drug Facts
| NPI NUMBER | 1245269869 | |
| NPPES Provider LastName | JENSIK | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 606123841 | |
| NPPES Provider State | IL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 6982.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 61.0 | |
| Percent Opioid Claims | 0.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245269869 |
| Last Name Of The Provider | JENSIK |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. John Q. Cook, MD |
|
|
Dr. Philip A. Casella, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Komar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald K. Wood, MD |
|
Dr. Abraham Saper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia A. Buono, DO |
|
|
Dr. Jose R. Cintron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristine S. Corkum, MD |
|
|
Dr. Alex W. Farnand, MD |
|
|
Dr. Kristin D. Doffing, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bohdan Kroczek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher E. Lai, MD |
|
|
Dr. Jae W. Lee, MD |
|
|
Dr. Raquel E. Redondo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kun-Tai Hsu, MD |
|
|
Dr. Ann M. Wells, DO |